Gilead Sciences Submits New Drug Application for Remdesivir as a COVID-19 Treatment

Gilead Sciences Submits New Drug Application for Remdesivir as a COVID-19 Treatment

Right now, the antiviral is being administered to coronavirus patients under an emergency use authorization, which is more limited.